Patient-Reported Symptoms in the Global Multiple System Atrophy Registry

Mov Disord Clin Pract. 2022 Aug 29;9(7):967-971. doi: 10.1002/mdc3.13544. eCollection 2022 Oct.

Abstract

Background: The Global Multiple System Atrophy Registry (GLOMSAR) was established in 2013. It is an online patient-reported contact registry open and free that relies on self-reported diagnosis by the patient or caregiver.

Objectives: To report the demographics of patients enrolled in GLOMSAR and the results of an ancillary online symptom questionnaire.

Methods: Patients enrolled in GLOMSAR were invited to complete a custom-designed online questionnaire about disease onset and symptom prevalence.

Results: At the time of writing, there were 1083 participants in GLOMSAR, of which 33% (365) completed the questionnaire. The onset and frequency of most symptoms was similar to those reported in the literature in physician-reported studies. Some were understudied or not typically associated with multiple system atrophy (MSA), including reduced female sexual sensation (55%), forgetfulness (60%), pseudobulbar affect (37%), olfactory changes (36%), and visual hallucinations (21%).

Conclusions: Patient-reported studies and ancillary online questionnaires are valid, underused research tools useful to advance our knowledge on understudied MSA features and highlight the patients' voice.

Keywords: burden; multiple system atrophy; patient advocacy groups; patient registries; synucleinopathies.